MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts

NEW YORK, May 12, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts

http://www.reportlinker.com/p02114423/MediPoint-Neurovascular-Interventions---South-America-Analysis-and-Market-Forecasts.html

MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts

Summary

The global neurovascular interventions market is a vast, double-digit market that consists of innovative and emerging technologies. Rapid advances in the field of neurovascular interventions and development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. The neurovascular interventions market consists of four device segments including embolization, revascularization, mechanicalthrombectomy and access/support devices.

The neurovascular interventions market will be driven by the rising prevalence of disease, the growing aging population, and the potential cost savings. The adoption of innovative technologies such as flow diverters and stent retrievers in Brazil will depend on the cost of, and availability of reimbursement for these devices. Flow diverters and stent retrievers are currently not reimbursed by the Brazilian public healthcare system and are associated with high costs.

Scope

- An overview of Neurovascular Interventions, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized South America Neurovascular Interventions market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020.
- Investigation of current and future market competition for Neurovascular Interventions.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the Neurovascular Interventions sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL) as well as doctors

Reasons to buy

- Understand the trends shaping and driving the South America Neurovascular Interventions market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in South America Neurovascular Interventions market through 2018.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What's the next big thing in South America Neurovascular Interventions market landscape? Identify, understand and capitalize.
1 Table of Contents

2 Introduction 26
2.1 Catalyst 27
3 Clinical Outcomes 28
3.1 Disease Management 28
3.1.1 Intracranial Aneurysms 28
3.1.2 Intracranial Arteriovenous Malformations 29
3.1.3 Dural Arteriovenous Fistulas 30
3.1.4 Intracranial and Extracranial Atherosclerotic Disease 30
3.1.5 Stroke 31
3.2 Treatment Modalities 32
3.2.1 Overview 32
3.2.2 Medical/Chemical Therapy 34
3.2.3 Surgical Therapy 34

3.2.4 Endovascular Therapy 36
4 Industry Overview 46
4.1 Overview 46
4.2 Procedure Trends 46
4.2.1 Intracranial Aneurysms 46
4.2.2 Intracranial Arteriovenous Malformations 48
4.2.3 Atherosclerotic Disease 49
4.2.4 Acute Ischemic Stroke 50
4.3 Market Access 51
4.3.1 Regulatory Process 52
4.3.2 Physician Perception and Decision Making Process 53
4.3.3 Variations in Clinical Practice 59
4.3.4 Lack of Clinical Data 59
4.3.5 Cost-Considerations 60
4.3.6 Reimbursement Trends 61
4.4 Mergers and Acquisitions/Key Partnerships 63
4.4.1 Covidien and Nfocus Neuromedical 63
4.4.2 Stryker Corporation and Surpass Medical 63
4.4.3 Covidien and MindFrame 64
4.4.4 Covidien and Reverse Medical Corporation 64

4.4.5 Stryker Corporation and Boston Scientific Neurovascular 64
4.4.6 Stryker Corporation and Concentric Medical 65
4.4.7 Covidien and ev3 65
4.4.8 Medtronic and Invatec 65
4.4.9 Johnson & Johnson and Micrus Endovascular 66
4.4.10 ev3 and Chestnut Medical Technologies 66
4.4.11 Boston Scientific Corporation and Guidant Corporation 67
4.5 Economic Impact 67
4.5.1 Economic Impact of Intracranial Aneurysms and Arteriovenous Malformations 68
4.5.2 Economic Impact of Stroke 69
5 Unmet Needs 70
5.1 Overview 70
5.2 Need for Practice, Performance, and Physician Training Guidelines 70
5.3 Lack of Clinical Data 71
5.4 Improve Management of Acute Ischemic Stroke 72
5.5 Address Complications of Surgical Therapy 74
5.6 Addressing the Challenges of Surgical Clipping 74
5.7 Lack of Optimal Treatment Strategy for Unruptured Intracranial Aneurysms 75
5.8 Need for Effective Therapies for Complex Aneurysm Morphologies and Sizes 76
5.9 Difficulty in Treating Intracranial Arteriovenous Malformations 77
5.10 Eliminating Mechanisms of Failure with Balloon Angioplasty 78
5.11 Addressing Challenges of Neurovascular Stenting 79
5.11.1 Risk of Post-Procedural Complications 79
5.11.2 In-Stent Restenosis 80
5.11.3 Stent Navigation 80
5.12 Complications of Dual Antiplatelet Therapy 81
5.13 Need to Improve Medical Therapy 81

5.14 Improve Ease of Access 82
6 Market Opportunity Analysis 83
6.1 Neurovascular Interventions Market 83
6.2 Improve Neurointerventional Device Design 83
6.3 Challenges in Treating Complex Intracranial Aneurysms and Arteriovenous Malformations 85
6.3.1 Intracranial Aneurysms 85
6.3.2 Intracranial Arteriovenous Malformations 86
6.4 Target Challenging Patient Populations 87
6.5 Optimize Care for Acute Ischemic Stroke Patients 87
6.6 Development of Drug-Eluting Devices 89
6.7 Emerging Markets 89
7 Market Drivers and Barriers 91
7.1 Market Drivers 91
7.1.1 Rising Prevalence of Disease 92
7.1.2 Improved Clinical Outcomes with Endovascular Coiling 93
7.1.3 Remodeling Techniques with Stent and Balloon-Assisted Coiling 94
7.1.4 Viable Therapeutic Option for Challenging/Complex Intracranial Aneurysms 96
7.1.5 Alternative Non-Coiling Embolization Devices for Aneurysm Treatment 97
7.1.6 Endovascular Embolization of Intracranial Arteriovenous Malformations 98
7.1.7 Imaging Assessment for Intracranial Arteriovenous Malformation Treatment 99
7.1.8 Stenting for Carotid Atherosclerotic Disease 99
7.1.9 Low-Profile Stent Systems 100
7.1.10 Improved Recanalization Rates with Mechanical Thrombectomy Devices 101
7.1.11 Cost Savings 103
7.1.12 Availability of Long-Term and Cost-Effective Data 103
7.2 Market Barriers 104
7.2.1 Complications of Neurointerventional Procedures and Devices 104

7.2.2 Lack of Clinical Data 110
7.2.3 High Cost of Treatment 110
7.2.4 Lack of Reimbursement 112
7.2.5 Lack of Superiority of Bioactive/Coated Coils 113
7.2.6 Alternative Technologies for Stroke Therapy 114
7.2.7 Regulatory Challenges: US Food and Drug Administration and European Conformity Mark 114
7.2.8 Healthcare Cost-Cutting and Reimbursement 115
7.2.9 Availability of Venture Capital 116
7.2.10 Medical Device Excise Tax 117
8 Competitive Assessment 118
8.1 Overview 118
8.2 South America Market Share 118
8.3 Marketed Products 119
8.3.1 Aachen Resonance 119
8.3.2 Abbott Vascular 121
8.3.3 Acandis 123
8.3.4 B. Braun 125
8.3.5 BALT Extrusion 126
8.3.6 Blockade Medical 132

8.3.7 Boston Scientific Corporation 133
8.3.8 Contego Medical 135
8.3.9 Cook Medical 135
8.3.10 Covidien 136
8.3.11 Gardia Medical 143
8.3.12 Gore Medical 144
8.3.13 InspireMD 146
8.3.14 ITGI Medical 147
8.3.15 Johnson & Johnson 148
8.3.16 Medikit 154
8.3.17 Medtronic 156
8.3.18 Merlin MD 158
8.3.19 MicroPort Scientific Corporation 160
8.3.20 Minvasys 162
8.3.21 Neuravi 163
8.3.22 Optimed 164
8.3.23 Penumbra 165
8.3.24 Phenox GmbH 169
8.3.25 Reverse Medical 171
8.3.26 Sequent Medical 173
8.3.27 Stryker Neurovascular Intervention 175
8.3.28 Terumo Corporation 182
8.3.29 Valor Medical 188
9 Pipeline Assessment 190
9.1 Overview 190
9.2 Pipeline by Stage of Development 191
9.3 Product Profiles 193
9.3.1 Aneurysm Occlusion Saddle 193
9.3.2 Ballstent Microcatheter 193
9.3.3 Blood Clot Removing Device 194
9.3.4 EKOS' EkoSonic Small Vessel Endovascular System 194
9.3.5 Flow-Diverting Thin-Film Nitinol Covered Stent 195
9.3.6 Ischemic Stroke System 195
9.3.7 Janjua Aneurysm Net 196
9.3.8 Multilayer Aneurysm Repair System 197

9.3.9 NAVIMAX 198
9.3.10 Palmaz Scientific Stents 199
9.3.11 Silk Road System 200
9.3.12 Transcranial Thrombectomy Catheter 201
10 Clinical Trial Analysis 202
10.1 Overview 202
10.2 Clinical Trials to Watch 203
10.2.1 Embolization 203
10.2.2 Flow Diversion 205
10.2.3 Revascularization 208
10.2.4 Mechanical Thrombectomy 210
11 Current and Future Players 212
11.1 Overview 212
11.2 Trends in Corporate Strategy 212
11.3 Company Profiles 214
11.3.1 BALT Extrusion 214
11.3.2 Covidien 217
11.3.3 Johnson & Johnson 220
11.3.4 Penumbra 225
11.3.5 Stryker Corporation 228
11.3.6 Terumo Corporation 230
11.3.7 Abbott Vascular 234
11.3.8 Boston Scientific Corporation 236
11.3.9 Cook Medical 238
11.3.10 Gore Medical 240
11.3.11 Medtronic 242
11.3.12 Aachen Resonance 245
11.3.13 Acandis 247
11.3.14 B. Braun 249
11.3.15 Blockade Medical 251
11.3.16 Contego Medical 252
11.3.17 Gardia Medical 253
11.3.18 InspireMD 255
11.3.19 ITGI Medical 257

11.3.20 Medikit 258
11.3.21 Merlin MD 259
11.3.22 MicroPort Scientific Corporation 261
11.3.23 Minvasys 262
11.3.24 Neuravi 264
11.3.25 Optimed 265
11.3.26 Phenox GmBH 267
11.3.27 Reverse Medical 268
11.3.28 Sequent Medical 270
11.3.29 Valor Medical 271
11.3.30 Other Companies 274
12 Market Outlook 276
12.1 South America 276
12.1.1 Brazil 276
13 Appendix 282
13.1 Bibliography 282
13.2 Abbreviations 303
13.3 Report Methodology 308
13.3.1 Overview 308
13.3.2 Coverage 308

13.3.3 Secondary Research 308
13.4 Physicians and Specialists Included in this Study 310
13.4.1 Vivek Gupta, MD 310
13.4.2 Zsolt Kulscár, MD, PhD 310
13.4.3 Salvatore Mangiafico, MD 310
13.4.4 Thanh Nguyen, MD, FRCPc 310
13.4.5 Eduardo Wajnberg, MD 310
13.4.6 Phil White, MD 311
13.4.7 Osama O Zaidat, MD, MS, FAAN, FAHA 311
13.5 Primary Research 312
13.5.1 Primary Research - Key Opinion Leader Interviews 312
13.5.2 Expert Panel Validation 312
13.6 Forecasting Methodology 313
13.7 About the Authors 315
13.7.1 Analysts 315
13.7.2 Global Head of Healthcare 316
13.8 About MediPoint 317
13.9 About GlobalData 317
13.10 Disclaimer 317

1.1 List of Tables

Table 1: Complications of Cerebral Artery Bypass Surgery 35
Table 2: Types of Cerebral Embolic Protection Devices 43
Table 3: Aachen Resonance Neurovascular Intervention Marketed Product 119
Table 4: Aachen Resonance Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 121
Table 5: Abbott Vascular Neurovascular Intervention Marketed Products 122
Table 6: Abbott Vascular Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 123
Table 7: Acandis Neurovascular Intervention Marketed Products 124
Table 8: Acandis Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 125
Table 9: B. Braun Neurovascular Intervention Marketed Product 126
Table 10: B. Braun Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 126
Table 11: BALT Extrusion Neurovascular Intervention Marketed Products 128
Table 12: BALT Extrusion Neurovascular Intervention Marketed Access Products 130
Table 13: BALT Extrusion Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 131
Table 14: Blockade Medical Neurovascular Intervention Marketed Product 132
Table 15: Blockade Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 133
Table 16: Boston Scientific Neurovascular Intervention Marketed Products 134
Table 17: Boston Scientific Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 134
Table 18: Contego Medical Neurovascular Intervention Marketed Product 135
Table 19: Contego Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 135
Table 20: Cook Medical Neurovascular Intervention Marketed Products 136
Table 21: Cook Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 136
Table 22: Covidien Neurovascular Interventional Marketed Products 138
Table 23: Covidien Neurovascular Intervention Marketed Access Products 141

Table 24: Covidien Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 142
Table 25: Gardia Medical Neurovascular Intervention Marketed Product 143
Table 26: Gardia Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 144
Table 27: Gore Medical Neurovascular Intervention Marketed Products 145
Table 28: Gore Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 145
Table 29: InspireMD Neurovascular Intervention Marketed Product 146
Table 30: InspireMD Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 146
Table 31: ITGI Medical Neurovascular Intervention Marketed Product 147
Table 32: ITGI Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 148
Table 33: Codman Neurovascular Marketed Embolization Products 149
Table 34: Codman Neurovascular Marketed Mechanical Thrombectomy and Access Products 151
Table 35: Codman Neurovascular's (Codman & Shurtleff) Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 152
Table 36: Cordis Corporation Marketed Neurointerventional Products 153
Table 37: Cordis Corporation Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 154
Table 38: Medikit Neurovascular Intervention Marketed Products 155
Table 39: Medikit Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 156
Table 40: Medtronic Neurovascular Intervention Marketed Products 157
Table 41: Medtronic Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 158
Table 42: Merlin MD Neurovascular Intervention Marketed Product 159
Table 43: Merlin MD Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 160
Table 44: MicroPort Scientific Corporation Neurovascular Intervention Marketed Products 161
Table 45: MicroPort Scientific Corporation Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 162

Table 46: Minvasys Neurovascular Intervention Marketed Product 163
Table 47: Minvasys Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 163
Table 48: Neuravi Neurovascular Intervention Marketed Product 164
Table 49: Neuravi Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 164
Table 50: Optimed Neurovascular Intervention Marketed Products 165
Table 51: Optimed Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 165
Table 52: Penumbra Neurovascular Intervention Marketed Products 166
Table 53: Penumbra Marketed Neurovascular Access Products 168
Table 54: Penumbra Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 169
Table 55: Phenox GmbH Neurovascular Intervention Marketed Products 170
Table 56: Phenox GmbH Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 171
Table 57: Reverse Medical Neurovascular Intervention Marketed Products 172
Table 58: Reverse Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 173
Table 59: Sequent Medical Neurovascular Intervention Marketed Products 174
Table 60: Sequent Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 175
Table 61: Stryker Neurovascular Intervention Marketed Products 177
Table 62: Stryker Neurovascular Intervention Marketed Mechanical Thrombectomy and Access Products 179
Table 63: Stryker Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 181
Table 64: Terumo Europe N.V. and Terumo Interventional Systems Marketed Neurointerventional Products 183
Table 65: Terumo Corporation Neurovascular Product Portfolio SWOT Analysis, 2014 184
Table 66: MicroVention Neurovascular Intervention Marketed Products 185
Table 67: MicroVention Marketed Neurovascular Access Products 187
Table 68: MicroVention Neurovascular Product Portfolio SWOT Analysis, 2014 188
Table 69: Valor Medical Neurovascular Intervention Marketed Products 189
Table 70: Valor Medical Neurovascular Intervention Product Portfolio SWOT Analysis, 2014 189
Table 71: Global Neurovascular Interventions Pipeline Products 192
Table 72: Aneurysm Occlusion Saddle SWOT Analysis, 2014 193

Table 73: EKOS EkoSonic SV System SWOT Analysis, 2014 194
Table 74: Flow-Diverting Thin-Film Nitinol Covered Stent SWOT Analysis, 2014 195
Table 75: Janjua Aneurysm Net SWOT Analysis, 2014 196
Table 76: Multilayer Aneurysm Repair System SWOT Analysis, 2014 197
Table 77: NAVIMAX SWOT Analysis, 2014 198
Table 78: Palmaz Scientific Stents SWOT Analysis, 2014 199
Table 79: Silk Road System SWOT Analysis, 2014 200
Table 80: BALT Extrusion Company Profile 215
Table 81: BALT Extrusion Neurovascular Intervention Marketed Products 216
Table 82: BALT Extrusion SWOT Analysis, 2014 217
Table 83: Covidien Company Profile 218
Table 84: Covidien Neurovascular Intervention Marketed Products 219
Table 85: Covidien SWOT Analysis, 2014 220
Table 86: Codman & Shurtleff Company Profile 221
Table 87: Codman & Shurtleff Neurovascular Intervention Marketed Products 222
Table 88: Codman & Shurtleff SWOT Analysis, 2014 223
Table 89: Cordis Corporation Company Profile 223
Table 90: Cordis Corporation Neurovascular Intervention Marketed Products 224
Table 91: Cordis Corporation SWOT Analysis, 2014 225
Table 92: Penumbra Company Profile 225

Table 93: Penumbra Neurovascular Intervention Marketed Products 227
Table 94: Penumbra SWOT Analysis, 2014 227
Table 95: Stryker Corporation Company Profile 228
Table 96: Stryker Corporation Neurovascular Intervention Marketed Products 229
Table 97: Stryker Corporation SWOT Analysis, 2014 230
Table 98: Terumo Corporation Company Profile 231
Table 99: Terumo Europe N.V. and Terumo Interventional Systems Neurovascular Intervention Marketed Products 232
Table 100: MicroVention Neurovascular Intervention Marketed Products 233
Table 101: Terumo Corporation SWOT Analysis, 2014 234
Table 102: Abbott Vascular Company Profile 234
Table 103: Abbott Vascular Neurovascular Intervention Marketed Products 235
Table 104: Abbott Vascular SWOT Analysis, 2014 236
Table 105: Boston Scientific Corporation Company Profile 237
Table 106: Boston Scientific Neurovascular Intervention Marketed Products 237
Table 107: Boston Scientific Corporation SWOT Analysis, 2014 238
Table 108: Cook Medical Company Profile 238
Table 109: Cook Medical Neurovascular Intervention Marketed Products 239
Table 110: Cook Medical SWOT Analysis, 2014 240
Table 111: Gore Medical Company Profile 241
Table 112: Gore Medical Neurovascular Intervention Marketed Products 241
Table 113: Gore Medical SWOT Analysis, 2014 242
Table 114: Medtronic Company Profile 243
Table 115: Medtronic Neurovascular Intervention Marketed Products 244
Table 116: Medtronic SWOT Analysis, 2014 244
Table 117: Aachen Resonance Company Profile 245
Table 118: Aachen Resonance Neurovascular Intervention Marketed Product 246

Table 119: Aachen Resonance SWOT Analysis, 2014 246
Table 120: Acandis Company Profile 247
Table 121: Acandis Neurovascular Intervention Marketed Products 248
Table 122: Acandis SWOT Analysis, 2014 248
Table 123: B. Braun Company Profile 249
Table 124: B. Braun Neurovascular Intervention Marketed Product 250
Table 125: B. Braun SWOT Analysis, 2014 250
Table 126: Blockade Medical Company Profile 251
Table 127: Blockade Medical Neurovascular Intervention Marketed Product 251
Table 128: Blockade Medical SWOT Analysis, 2014 252
Table 129: Contego Medical Company Profile 252
Table 130: Contego Medical Neurovascular Intervention Marketed Product 253
Table 131: Contego Medical SWOT Analysis, 2014 253
Table 132: Gardia Medical Company Profile 254
Table 133: Gardia Medical Neurovascular Intervention Marketed Product 254
Table 134: Gardia Medical SWOT Analysis, 2014 255
Table 135: InspireMD Company Profile 256
Table 136: InspireMD Neurovascular Intervention Marketed Product 256
Table 137: InspireMD SWOT Analysis, 2014 256
Table 138: ITGI Medical Company Profile 257
Table 139: ITGI Medical Neurovascular Intervention Marketed Product 257
Table 140: ITGI Medical SWOT Analysis, 2014 258
Table 141: Medikit Company Profile 258
Table 142: Medikit Neurovascular Intervention Marketed Products 259
Table 143: Medikit SWOT Analysis, 2014 259
Table 144: Merlin MD Company Profile 260
Table 145: Merlin MD Neurovascular Intervention Marketed Product 260
Table 146: Merlin MD SWOT Analysis, 2014 260

Table 147: MicroPort Scientific Corporation Company Profile 261
Table 148: MicroPort Scientific Corporation Neurovascular Intervention Marketed Products 261
Table 149: MicroPort Scientific Corporation SWOT Analysis, 2014 262
Table 150: Minvasys Company Profile 263
Table 151: Minvasys Neurovascular Intervention Marketed Product 263
Table 152: Minvasys SWOT Analysis, 2014 263
Table 153: Neuravi Company Profile 264
Table 154: Neuravi Neurovascular Intervention Marketed Product 264
Table 155: Neuravi SWOT Analysis, 2014 265
Table 156: Optimed Company Profile 266
Table 157: Optimed Neurovascular Intervention Marketed Products 266
Table 158: Optimed SWOT Analysis, 2014 266
Table 159: Phenox GmBH Company Profile 267
Table 160: Phenox GmbH Neurovascular Intervention Marketed Products 268
Table 161: Phenox GmBH SWOT Analysis, 2014 268
Table 162: Reverse Medical Company Profile 269
Table 163: Reverse Medical Neurovascular Intervention Marketed Products 269
Table 164: Reverse Medical SWOT Analysis, 2014 270
Table 165: Sequent Medical Company Profile 270
Table 166: Sequent Medical Neurovascular Intervention Marketed Products 271
Table 167: Sequent Medical SWOT Analysis, 2014 271
Table 168: Valor Medical Company Profile 272
Table 169: Valor Medical Neurovascular Intervention Marketed Products 272
Table 170: Valor Medical SWOT Analysis, 2014 273
Table 171: Other Companies in the Neurovascular Intervention Market, 2014 274
Table 172: Neurovascular Interventions Market Sales ($m) Forecast for Brazil, 2011–2020 276

1.2 List of Figures

Figure 1: Treatment Modalities - Neurovascular Interventions 33
Figure 2: Types of Stents Used for Neurovascular Interventions 42
Figure 3: Embolization Procedure Volume for Treating Intracranial Aneurysms, South America, 2011-2020 47
Figure 4: Embolization Procedure Volume for Treating Intracranial Arteriovenous Malformations, South America, 2011-2020 48
Figure 5: Revascularization Procedure Volume for Treating Atherosclerotic Disease, South America, 2011-2020 49
Figure 6: Mechanical Thrombectomy Procedure Volume for Treating Acute Ischemic Stroke, South America, 2011-2020 50
Figure 7: Neurointerventional Market Distribution, South America, 2013 118
Figure 8: Global Neurovascular Interventions Pipeline Products by Stage of Development, 2014 191
Figure 9: Brazilian Neurovascular Interventions Market ($m) for Cerebrovascular Applications, 2011-2020 277
Figure 10: Brazilian Embolization Device Market ($m) for Cerebrovascular Applications, 2011-2020 278
Figure 11: Brazilian Revascularization Device Market ($m) for Cerebrovascular Applications, 2011-2020 279
Figure 12: Brazilian Mechanical Thrombectomy Device Market ($m) for Cerebrovascular Applications, 2011-2020 280
Figure 13: Brazilian Access Device Market ($m) for Cerebrovascular Applications, 2011-2020 281

To order this report: MediPoint: Neurovascular Interventions - South America Analysis and Market Forecasts
http://www.reportlinker.com/p02114423/MediPoint-Neurovascular-Interventions---South-America-Analysis-and-Market-Forecasts.html

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker



RELATED LINKS
http://www.reportlinker.com

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.